NanoViricides, Inc.NNVCNYSE
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank13
Studio
Year-over-Year Change

Year-over-year operating income growth rate

Latest
-24.29%
↓ 772% vs avg
Percentile
P13
Within normal range
Streak
1 qtr
Consecutive declineDecelerating
Average
-2.78%
Historical baseline
PeriodValue
Q4 2025-24.29%
Q3 202515.07%
Q2 20255.94%
Q1 2025-9.23%
Q4 202435.00%
Q3 2024-32.47%
Q2 2024-25.31%
Q1 202412.65%
Q4 2023-7.54%
Q3 202344.74%
Q2 2023-103.03%
Q1 20231.27%
Q4 2022-13.04%
Q3 20229.51%
Q2 2022-0.27%
Q1 20226.91%
Q4 202126.48%
Q3 2021-25.94%
Q2 20211.58%
Q1 20218.05%
Q4 2020-0.95%
Q3 2020-23.94%
Q2 202027.95%
Q1 2020-55.55%
Q4 201917.78%
Q3 20198.33%
Q2 2019-4.11%
Q1 201912.08%
Q4 2018-16.19%
Q3 201810.67%
Q2 20185.61%
Q1 2018-1.02%
Q4 2017-7.32%
Q3 20170.73%
Q2 201714.10%
Q1 2017-13.84%
Q4 20165.85%
Q3 20162.22%
Q2 2016-21.86%
Q1 20162.01%